LIFECORE BIOMEDICAL, INC. Income Taxes Paid
LIFECORE BIOMEDICAL, INC. (LFCR) reported Income Taxes Paid of $19.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-05
- LIFECORE BIOMEDICAL, INC. income taxes paid, net for fiscal 2025 was $46.00K, a 36.11% decline from fiscal 2024.
- LIFECORE BIOMEDICAL, INC. income taxes paid, net for fiscal 2024 was $72.00K, a 213.04% increase from fiscal 2023.
- LIFECORE BIOMEDICAL, INC. income taxes paid, net for fiscal 2023 was $23.00K, a 94.78% decline from fiscal 2022.
- LIFECORE BIOMEDICAL, INC. income taxes paid, net for fiscal 2022 was $441.00K.
| Period end | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 7 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|
| 2026-06-30 | $19.00K 10-Q · filed 2026-08-05 | ||
| 2025-12-31 | -$12.00K 10-KT · filed 2026-03-16 | ||
| 2025-05-25 | -$81.00K 10-Q · filed 2026-08-05 | $46.00K 10-KT · filed 2026-03-16 | |
| 2024-11-24 | $127.00K 10-Q · filed 2025-01-02 | ||
| 2024-05-26 | $72.00K 10-KT · filed 2026-03-16 | ||
| 2023-11-26 | $70.00K 10-Q · filed 2025-01-02 | ||
| 2023-05-28 | $23.00K 10-K · filed 2024-08-26 | ||
| 2022-05-29 | $441.00K 10-K · filed 2024-08-26 | ||
| 2021-05-30 | -$7.68M 10-K · filed 2024-03-20 | ||
| 2020-05-31 | -$1.12M 10-K/A · filed 2023-03-16 | ||
| 2019-05-26 | -$1.96M 10-K · filed 2021-07-29 | ||
| 2018-05-27 | $283.00K 10-K · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |